Article
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study).
BMC cancer - 19 Jun 2013
Young Elisa J, Tabrizi Sepehr N, Brotherton Julia Ml, Wark John D, Pyman Jan, Saville Marion, Wrede C David, Jayasinghe Yasmin, Tan Jeffrey, Gertig Dorota M, Pitts Marian, Garland Suzanne M
Abstract excerpt
BACKGROUND: The quadrivalent human papillomavirus vaccine has been provided in Australia through the National Human Papillomavirus Vaccination Program since April 2007. National registry data demonstrates good coverage of the vaccine, with 73% of school-aged girls having received all three doses. To evaluate the effectiveness of the program, we propose a two-pronged approach. In one (sub study A), the prevalence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.